FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3210952634> ?p ?o ?g. }

• W3210952634 endingPage "204209862110523" @default.
• W3210952634 startingPage "204209862110523" @default.
• W3210952634 abstract "Introduction: The decision to deprescribe medications used for both disease prevention and symptom control (dual-purpose medications or DPMs) is often challenging for clinicians. We aim to establish the impact of deprescribing DPMs on patient-related outcomes for older adults near end-of-life (EOL). Methods: This systematic review was conducted according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guideline. Literature was searched on PubMed, EMBASE, CINAHL, PsycINFO and Google Scholar until December 2019 for studies on deprescribing intervention with a control group (with or without randomisation); targeting ⩾65-year olds, at EOL, with at least one life-limiting illness and at least one potentially inappropriate DPM. We were interested in any patient-related outcomes. Studies with similar outcome assessment criteria were subjected to meta-analysis and narrative synthesis otherwise. The risk of bias was assessed using Cochrane Risk of Bias and ROBINS-I tools for randomised controlled trials (RCTs) and quasi-experimental non-randomised controlled studies, respectively. Results: Five studies covering 689 participants with mean age 81.6–85.7 years, the majority (74.6–100%) with dementia were included. The risk of bias was moderate to low. The deprescribing of DPMs lowered the risk of mortality (risk ratio (RR) = 0.59, 95% confidence interval (CI) = 0.44–0.79) and referral to acute care facilities (RR = 0.40, 95% CI = 0.22–0.73), but did not have a significant impact on the risk of falls, non-vertebral fracture, emergency presentation, unplanned hospital admission, or general practitioner visits. No significant difference was observed in the quality of life, physical and cognitive functions between the intervention and control groups. Conclusion: There is some evidence that deprescribing of DPMs for older adults near the EOL can lower the risk of mortality and referral to acute care facilities, but there are insufficient good-quality studies powered to confirm a benefit in terms of quality of life, physical or cognitive function, health service utilisation and adverse events. Plain Language Summary What is the health impact of withdrawal or dose reduction of medication used for disease prevention and symptom control in older adults near end-of-life? Introduction: Older adults (aged ⩾ 65 years) with advanced diseases such as cancer, dementia, and organ failure tend to have a limited life expectancy. With the progression of these diseases towards the end-of-life, the intensity for day-to-day supportive care becomes increasingly necessary. The use of medications for symptom management is a critical part of such care, but the use of medications for long-term disease prevention can become irrelevant due to the already shortened life expectancy and may become harmful due to alterations in physiology and pharmacology associated with age and frailty. This necessitates the withdrawal or dose reduction of inappropriate medications, the process called deprescribing. The decision to deprescribe medications used for both disease prevention and symptom control (DPMs) in this population is often challenging for clinicians. In this context, whether deprescribing of DPMs can improve patient-related health outcomes is unknown. Methods: Evidence from the literature was reviewed and analysed, and the quality of studies was assessed. Five studies were identified, which had 689 participants with an average age above 80 years and mostly suffering from dementia. Results: The analysis of these studies showed deprescribing of DPMs lowered the risk of death and referral to acute care facilities at 12 months but had no significant impact on falls, non-vertebral fractures, emergency presentations, unplanned hospital admission, general practitioner visits, quality of life, physical and mental functions. Conclusion: In conclusion, there were insufficient numbers of high-quality studies powered to confirm whether deprescribing of DPMs reduces adverse events, health service use, or improves the quality of life or functioning in older adults near the end of life." @default.
• W3210952634 created "2021-11-08" @default.
• W3210952634 creator A5024519228 @default.
• W3210952634 creator A5054331664 @default.
• W3210952634 creator A5058260554 @default.
• W3210952634 creator A5066799340 @default.
• W3210952634 creator A5077461898 @default.
• W3210952634 date "2021-01-01" @default.
• W3210952634 modified "2023-10-13" @default.
• W3210952634 title "Impact of deprescribing dual-purpose medications on patient-related outcomes for older adults near end-of-life: a systematic review and meta-analysis" @default.
• W3210952634 cites W1500270423 @default.
• W3210952634 cites W1970749495 @default.
• W3210952634 cites W1976850150 @default.
• W3210952634 cites W1984749403 @default.
• W3210952634 cites W1986151723 @default.
• W3210952634 cites W2014818337 @default.
• W3210952634 cites W2016936949 @default.
• W3210952634 cites W2046737621 @default.
• W3210952634 cites W2055643091 @default.
• W3210952634 cites W2061440291 @default.
• W3210952634 cites W2100357908 @default.
• W3210952634 cites W2112556256 @default.
• W3210952634 cites W2122022552 @default.
• W3210952634 cites W2131656660 @default.
• W3210952634 cites W2131914658 @default.
• W3210952634 cites W2133346238 @default.
• W3210952634 cites W2140790753 @default.
• W3210952634 cites W2147234629 @default.
• W3210952634 cites W2171541729 @default.
• W3210952634 cites W2187253672 @default.
• W3210952634 cites W2270938952 @default.
• W3210952634 cites W2288614434 @default.
• W3210952634 cites W2462821162 @default.
• W3210952634 cites W2465454303 @default.
• W3210952634 cites W2475837427 @default.
• W3210952634 cites W2522136028 @default.
• W3210952634 cites W2525657973 @default.
• W3210952634 cites W2527588861 @default.
• W3210952634 cites W2562876390 @default.
• W3210952634 cites W2586552843 @default.
• W3210952634 cites W2744117543 @default.
• W3210952634 cites W2751007471 @default.
• W3210952634 cites W2784379896 @default.
• W3210952634 cites W2792535583 @default.
• W3210952634 cites W2801487011 @default.
• W3210952634 cites W2805388957 @default.
• W3210952634 cites W2888516414 @default.
• W3210952634 cites W2889581152 @default.
• W3210952634 cites W2896742755 @default.
• W3210952634 cites W2906338162 @default.
• W3210952634 cites W2907983377 @default.
• W3210952634 cites W2909281934 @default.
• W3210952634 cites W2922712967 @default.
• W3210952634 cites W2955197445 @default.
• W3210952634 cites W2959215651 @default.
• W3210952634 cites W2971984451 @default.
• W3210952634 cites W2974315489 @default.
• W3210952634 cites W2980170029 @default.
• W3210952634 cites W2995811178 @default.
• W3210952634 cites W3093040123 @default.
• W3210952634 doi "https://doi.org/10.1177/20420986211052343" @default.
• W3210952634 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8543710" @default.
• W3210952634 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34707802" @default.
• W3210952634 hasPublicationYear "2021" @default.
• W3210952634 type Work @default.
• W3210952634 sameAs 3210952634 @default.
• W3210952634 citedByCount "7" @default.
• W3210952634 countsByYear W32109526342022 @default.
• W3210952634 countsByYear W32109526342023 @default.
• W3210952634 crossrefType "journal-article" @default.
• W3210952634 hasAuthorship W3210952634A5024519228 @default.
• W3210952634 hasAuthorship W3210952634A5054331664 @default.
• W3210952634 hasAuthorship W3210952634A5058260554 @default.
• W3210952634 hasAuthorship W3210952634A5066799340 @default.
• W3210952634 hasAuthorship W3210952634A5077461898 @default.
• W3210952634 hasBestOaLocation W32109526341 @default.
• W3210952634 hasConcept C118552586 @default.
• W3210952634 hasConcept C126322002 @default.
• W3210952634 hasConcept C142724271 @default.
• W3210952634 hasConcept C168563851 @default.
• W3210952634 hasConcept C17744445 @default.
• W3210952634 hasConcept C177713679 @default.
• W3210952634 hasConcept C189708586 @default.
• W3210952634 hasConcept C194828623 @default.
• W3210952634 hasConcept C199539241 @default.
• W3210952634 hasConcept C27415008 @default.
• W3210952634 hasConcept C2776478404 @default.
• W3210952634 hasConcept C2776484012 @default.
• W3210952634 hasConcept C2779473830 @default.
• W3210952634 hasConcept C2779549880 @default.
• W3210952634 hasConcept C2780182762 @default.
• W3210952634 hasConcept C2781145037 @default.
• W3210952634 hasConcept C36434225 @default.
• W3210952634 hasConcept C44249647 @default.
• W3210952634 hasConcept C71924100 @default.
• W3210952634 hasConcept C82789193 @default.
• W3210952634 hasConcept C95190672 @default.
• W3210952634 hasConceptScore W3210952634C118552586 @default.

• next